The Defense Advanced Research Projects Agency has selected teams from Yale University, University of Washington and Broad Institute to support a program meant to develop therapeutics for multidrug resistant microbial infections. The
We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them on our Privacy Policy. If you continue to use this site, you consent to our use of cookies.